Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia\u2019s first study of whole-body screening for young people with neurofibromatosis type 1.<\/p>\n\n\n\n
Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support from the NORTH Foundation.<\/p>\n\n\n\n
Neurofibromatosis type 1 (NF1) is an inherited condition that affects 1 in 2,500 people.<\/p>\n\n\n\n
Young adults with the condition face a 20-fold increase in cancer-related mortality, yet there are currently no routine imaging guidelines in Australia.<\/p>\n\n\n\n
The study will recruit 50 patients aged 18-40 years old to assess the feasibility and psychosocial impacts of the whole-body MRI screening program.<\/p>\n\n\n\n
Dr Siow said their project could be life-changing.<\/p>\n\n\n\n
\n\u201cThis is the first study of whole-body MRI screening of people with neurofibromatosis type 1 in Australia,\u201d she said.<\/p>\n\n\n\n
\u201cWe have the opportunity for early detection in this group of young people who have a high cancer risk.\u201d<\/p>\n<\/blockquote>\n\n\n\n
The research will be conducted through the Royal North Shore Neurofibromatosis Clinic, a statewide service led by Associate Professor Mimi Berman, in collaboration with national partner Omico.<\/p>\n\n\n\n
The project aims to inform national guidelines and significantly improve outcomes through earlier detection and treatment of cancer. <\/p>\n\n\n\n
The Royal North Shore Campus Research Grants scheme funds exceptional research to improve standards of care and health outcomes locally and regionally.<\/p>\n\n\n\n
Applications for the 2025 grants are now open, offering grants of up to $150,000.<\/p>\n\n\n\n
Researchers interested in the opportunity can email nslhd-researchgrants@health.nsw.gov.au<\/p>\n","protected":false},"author":1,"featured_media":2524,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[16,15],"tags":[23],"research-group-tax":[],"primary-research-area":[],"class_list":["post-2523","news","type-news","status-publish","has-post-thumbnail","hentry","category-new-treatment","category-research-excellence","tag-cancer"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop.webp",550,380,false],"thumbnail":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop-150x150.webp",150,150,true],"medium":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop-300x207.webp",300,207,true],"medium_large":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop.webp",550,380,false],"large":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop.webp",550,380,false],"1536x1536":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop.webp",550,380,false],"2048x2048":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/09\/thumb_Blog_Ramsay-NFT-Mimi-Sue-Faye_w550_h380_fcrop.webp",550,380,false]},"uagb_author_info":{"display_name":"ict-wordpress-support@sydney.edu.au","author_link":"https:\/\/kollinginstitute.org.au\/news_demo\/author\/ict-wordpress-supportsydney-edu-au\/"},"uagb_comment_info":0,"uagb_excerpt":"Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia\u2019s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support…","_links":{"self":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news\/2523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news\/2523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/media\/2524"}],"wp:attachment":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/media?parent=2523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/categories?post=2523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/tags?post=2523"},{"taxonomy":"research-group-tax","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/research-group-tax?post=2523"},{"taxonomy":"primary-research-area","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/primary-research-area?post=2523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}